Villarin, Baby Boy .

HRN: 28-84-94  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/23/2026
04/30/2026
IV
21 Mg
Q 36 Hours
T/C Neonatal Sepsis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: